FREE SHIPPING over $40
OVER 9000 FIVE-STAR REVIEWS
5% OFF ALL SUBSCRIPTIONS
100% HAPPINESS GUARANTEE
Analyze Diet
0
Home / Equine Research Bank / PLoS One / Muscle glycogen concentrations and response to diet and exer...
PloS one2018; 13(9); e0203467; doi: 10.1371/journal.pone.0203467

Muscle glycogen concentrations and response to diet and exercise regimes in Warmblood horses with type 2 Polysaccharide Storage Myopathy.

Abstract: Type 1 polysaccharide storage myopathy (PSSM1) is a glycogen storage disorder of known cause whereas the basis for type 2 PSSM (PSSM2) is unknown. The same diet and exercise regime prescribed for PSSM1 is recommended for PSSM2; however, the benefit of these recommendations for PSSM2 is undocumented. The objectives of this study were to determine traits of PSSM2 Warmblood horses (WB), determine the changes in exercise responses that occur with a recommended low-starch/fat-supplemented diet and exercise regime, and determine if glycogen concentrations correspond to the severity of signs. Owners of PSSM2 WB (2008-2016), completed a retrospective questionnaire regarding their horse. Glycogen concentrations were analyzed in skeletal muscle of PSSM2 WB (n = 36) obtained prior to recommendations and in control WB with no evident myopathy (n = 23). Chi-square, Fisher's exact, McNemar's tests with Bonferroni correction and Mann Whitney testing were utilized. Abnormal exercise responses reported by owners, began at approximately 6 years of age and included a decline in performance, a reluctance to collect and reluctance to go forward in over 50% of horses. With the recommended diet and exercise regime, 80% of PSSM2 WB owners reported an overall improvement with significant decreases in the proportion of horses showing a decline in performance and rhabdomyolysis. However, 53% of PSSM2 WB were still not advancing as expected with reluctance to go forward and collect persisting in approximately one third of horses. Median muscle glycogen concentrations did not differ between PSSM2 WB and WB with no evident myopathy. PSSM2 WB with the highest glycogen concentrations were significantly more likely to show a decline in performance than those with lower glycogen concentrations. In conclusion, diet and exercise recommendations ideal for PSSM1 improve but do not eliminate the decline in performance and reluctance to go forward under saddle characteristic of PSSM2.
Get Full Text
Publication Date: 2018-09-05 PubMed ID: 30183782PubMed Central: PMC6124783DOI: 10.1371/journal.pone.0203467Google Scholar: Lookup
The Equine Research Bank provides access to a large database of publicly available scientific literature. Inclusion in the Research Bank does not imply endorsement of study methods or findings by Mad Barn.
LinkedInCopy
  • Journal Article
  • Research Support
  • Non-U.S. Gov't

Summary

This research summary has been generated with artificial intelligence and may contain errors and omissions. Refer to the original study to confirm details provided. Submit correction.

The study investigated the effect of diet and exercise on Warmblood horses suffering from type 2 Polysaccharide Storage Myopathy (PSSM2), a glycogen storage disorder. It was observed that the affected horses benefited from a recommended low-starch and fat-supplemented diet along with exercise, although problems like performance decline and reluctance to move forward persisted in some cases.

Objectives and Procedures

  • The research aimed to delve into characteristics of PSSM2 in Warmblood horses, observe the changes in their exercise response to a prescribed, low-starch, fat-supplemented diet and exercise regime and determine the impact of glycogen concentrations on the severity of symptoms.
  • PSSM2 horse owners were asked to fill a retrospective questionnaire about their horses. The glycogen concentrations in the skeletal muscle of these horses were analyzed. This group was compared with a control group of Warmblood horses that didn’t show any signs of myopathy.
  • The statistical tests used for the study included Chi-square, Fisher’s exact, McNemar’s tests with a Bonferroni correction, and Mann Whitney testing.

Findings

  • Owners reported abnormal exercise responses, such as a decline in performance and reluctance to collect and move forward, starting at approximately 6 years of age in over half of the horses.
  • After implementing the recommended diet and exercise regime, 80% of PSSM2 horse owners reported an overall improvement with a significant drop in the proportion of horses showing performance decline and suffering from rhabdomyolysis.
  • Despite these improvements, about 53% of PSSM2 horses didn’t make expected progress, showing continued reluctance to move forward and gather – an issue that persisted in roughly a third of horses.
  • There were no significant differences in muscle glycogen concentrations between PSSM2 horses and those with no evident myopathy.
  • PSSM2 horses having the highest glycogen concentrations were more likely to experience a performance downfall compared to horses with lower glycogen concentrations.

Conclusion

  • The researchers concluded that while the diet and exercise regime suitable for horses with type 1 polysaccharide storage myopathy (PSSM1) does lead to some improvement, it’s not sufficient to entirely counterbalance the performance issues and reluctance to move forward often exhibited by horses with PSSM2.

Cite This Article

APA
Williams ZJ, Bertels M, Valberg SJ. (2018). Muscle glycogen concentrations and response to diet and exercise regimes in Warmblood horses with type 2 Polysaccharide Storage Myopathy. PLoS One, 13(9), e0203467. https://doi.org/10.1371/journal.pone.0203467

Publication

PloS one
ISSN: 1932-6203
NlmUniqueID: 101285081
Country: United States
Language: English
Volume: 13
Issue: 9
Pages: e0203467
PII: e0203467

Researcher Affiliations

Williams, Zoë J
  • McPhail Equine Performance Center, Department of Large Animal Clinical Sciences, College of Veterinary Medicine, Michigan State University, East Lansing, Michigan, United States of America.
Bertels, Megan
  • McPhail Equine Performance Center, Department of Large Animal Clinical Sciences, College of Veterinary Medicine, Michigan State University, East Lansing, Michigan, United States of America.
Valberg, Stephanie J
  • McPhail Equine Performance Center, Department of Large Animal Clinical Sciences, College of Veterinary Medicine, Michigan State University, East Lansing, Michigan, United States of America.

MeSH Terms

  • Animal Feed
  • Animals
  • Glycogen / metabolism
  • Glycogen Storage Disease Type II / metabolism
  • Glycogen Storage Disease Type II / physiopathology
  • Glycogen Storage Disease Type II / therapy
  • Glycogen Storage Disease Type II / veterinary
  • Horse Diseases / metabolism
  • Horse Diseases / physiopathology
  • Horse Diseases / therapy
  • Horses / metabolism
  • Muscle, Skeletal / metabolism
  • Muscle, Skeletal / pathology
  • Muscular Diseases / metabolism
  • Muscular Diseases / physiopathology
  • Muscular Diseases / therapy
  • Muscular Diseases / veterinary
  • Physical Conditioning, Animal
  • Starch / pharmacology

Conflict of Interest Statement

Williams, Bertels – no conflicts of interest. Valberg and colleagues license the PSSM1 genetic test and receive royalties from the test. This does not alter our adherence to PLOS ONE policies on sharing data and materials.

References

This article includes 33 references
  1. Valberg SJ, Cardinet GH 3rd, Carlson GP, DiMauro S. Polysaccharide storage myopathy associated with recurrent exertional rhabdomyolysis in horses.. Neuromuscul Disord 1992;2(5-6):351-9.
    pubmed: 1284408doi: 10.1016/s0960-8966(06)80006-4google scholar: lookup
  2. Valentine BA, Cooper BJ. Incidence of polysaccharide storage myopathy: necropsy study of 225 horses.. Vet Pathol 2005 Nov;42(6):823-7.
    doi: 10.1354/vp.42-6-823pubmed: 16301580google scholar: lookup
  3. McCue ME, Valberg SJ, Miller MB, Wade C, DiMauro S, Akman HO, Mickelson JR. Glycogen synthase (GYS1) mutation causes a novel skeletal muscle glycogenosis.. Genomics 2008 May;91(5):458-66.
    doi: 10.1016/j.ygeno.2008.01.011pmc: PMC2430182pubmed: 18358695google scholar: lookup
  4. McCue ME, Valberg SJ, Lucio M, Mickelson JR. Glycogen synthase 1 (GYS1) mutation in diverse breeds with polysaccharide storage myopathy.. J Vet Intern Med 2008 Sep-Oct;22(5):1228-33.
    doi: 10.1111/j.1939-1676.2008.0167.xpubmed: 18691366google scholar: lookup
  5. Stanley RL, McCue ME, Valberg SJ, Mickelson JR, Mayhew IG, McGowan C, Hahn CN, Patterson-Kane JC, Piercy RJ. A glycogen synthase 1 mutation associated with equine polysaccharide storage myopathy and exertional rhabdomyolysis occurs in a variety of UK breeds.. Equine Vet J 2009 Jul;41(6):597-601.
    pubmed: 19803057doi: 10.2746/042516409x407611google scholar: lookup
  6. Valberg SJ, MacLeay JM, Mickelson JR. Exertional rhabdomyolysis and polysaccharide storage myopathy in horses.. Compendium on continuing education for the practicing veterinarian 1997 September;19(9):1077–85.
  7. Valentine BA, Hintz HF, Freels KM, Reynolds AJ, Thompson KN. Dietary control of exertional rhabdomyolysis in horses.. J Am Vet Med Assoc 1998 May 15;212(10):1588-93.
    pubmed: 9604030
  8. Valentine BA, Van Saun RJ, Thompson KN, Hintz HF. Role of dietary carbohydrate and fat in horses with equine polysaccharide storage myopathy.. J Am Vet Med Assoc 2001 Dec 1;219(11):1537-44.
    pubmed: 11759989doi: 10.2460/javma.2001.219.1537google scholar: lookup
  9. Ribeiro WP, Valberg SJ, Pagan JD, Gustavsson BE. The effect of varying dietary starch and fat content on serum creatine kinase activity and substrate availability in equine polysaccharide storage myopathy.. J Vet Intern Med 2004 Nov-Dec;18(6):887-94.
    pubmed: 15638274doi: 10.1892/0891-6640(2004)18<887:teovds>2.0.co;2google scholar: lookup
  10. Annandale EJ, Valberg SJ, Mickelson JR, Seaquist ER. Insulin sensitivity and skeletal muscle glucose transport in horses with equine polysaccharide storage myopathy.. Neuromuscul Disord 2004 Oct;14(10):666-74.
    doi: 10.1016/j.nmd.2004.05.007pubmed: 15351424google scholar: lookup
  11. Firshman AM, Valberg SJ, Bender JB, Finno CJ. Epidemiologic characteristics and management of polysaccharide storage myopathy in Quarter Horses.. Am J Vet Res 2003 Oct;64(10):1319-27.
    pubmed: 14596472doi: 10.2460/ajvr.2003.64.1319google scholar: lookup
  12. Hunt LM, Valberg SJ, Steffenhagen K, McCue ME. An epidemiological study of myopathies in Warmblood horses.. Equine Vet J 2008 Mar;40(2):171-7.
    doi: 10.2746/042516408X244262pubmed: 18089471google scholar: lookup
  13. McGowan CM, Menzies-Gow NJ, McDiarmid AM, Patterson-Kane JC. Four cases of equine polysaccharide storage myopathy in the United Kingdom.. Vet Rec 2003 Jan 25;152(4):109-12.
    pubmed: 12572940doi: 10.1136/vr.152.4.109google scholar: lookup
  14. Lewis SS, Nicholson AM, Williams ZJ, Valberg SJ. Clinical characteristics and muscle glycogen concentrations in warmblood horses with polysaccharide storage myopathy.. Am J Vet Res 2017 Nov;78(11):1305-1312.
    doi: 10.2460/ajvr.78.11.1305pubmed: 29076373google scholar: lookup
  15. Valberg SJ, McCue ME, Mickelson JR. The interplay of genetics, exercise, and nutrition in polysaccharide storage myopathy.. Journal of Equine Veterinary Science 2011 May 1;31(5):205–10.
  16. Creswell JW. Mixed methods designs.. Educational research: Planning, conducting, and evaluating quantitative and qualitative research 2005:509–29.
  17. Dohoo IR, Martin W, Stryhn H. Veterinary epidemiologic research.. Charlottetown, Canada: AVC Incorporated; 2003: 57–72.
  18. Likert R. A technique for the measurement of attitudes.. Archives of psychology 1932.
  19. Valberg SJ, McKenzie EC, Eyrich LV, Shivers J, Barnes NE, Finno CJ. Suspected myofibrillar myopathy in Arabian horses with a history of exertional rhabdomyolysis.. Equine Vet J 2016 Sep;48(5):548-56.
    doi: 10.1111/evj.12493pmc: PMC4833696pubmed: 26234161google scholar: lookup
  20. Lowry OH, Passonneau JV. A flexible system of enzymatic analysis. Acad. Press, New York: 1972.
  21. Sun X, Yang Z. Generalized McNemar’s test for homogeneity of the marginal distributions.. SAS Global forum 2008 March 16 (Vol. 382, pp. 1–10).
  22. Valberg SJ, Nicholson AM, Lewis SS, Reardon RA, Finno CJ. Clinical and histopathological features of myofibrillar myopathy in Warmblood horses.. Equine Vet J 2017 Nov;49(6):739-745.
    pmc: PMC5640499pubmed: 28543538doi: 10.1111/evj.12702google scholar: lookup
  23. Walters JM, Parkin T, Snart HA, Murray RC. Current management and training practices for UK dressage horses.. Comparative Exercise Physiology 2008 May;5(2):73–83.
  24. Kold SE, Dyson SJ. Lameness in the dressage horse. Diagnosis and Management of Lameness in the Horse (Second Edition) 2011 (pp. 1112–1123).
  25. Dyson S, Murray R. Pain associated with the sacroiliac joint region: a clinical study of 74 horses.. Equine Vet J 2003 May;35(3):240-5.
    pubmed: 12755425doi: 10.2746/042516403776148255google scholar: lookup
  26. Dyson S, Murray R, Branch M, Harding E. The sacroiliac joints: evaluation using nuclear scintigraphy. Part 2: Lame horses.. Equine Vet J 2003 May;35(3):233-9.
    pubmed: 12755424doi: 10.2746/042516403776148282google scholar: lookup
  27. Greve L, Dyson S. Saddle fit and management: An investigation of the association with equine thoracolumbar asymmetries, horse and rider health.. Equine Vet J 2015 Jul;47(4):415-21.
    doi: 10.1111/evj.12304pubmed: 24905610google scholar: lookup
  28. Conzemius MG, Evans RB. Caregiver placebo effect for dogs with lameness from osteoarthritis.. J Am Vet Med Assoc 2012 Nov 15;241(10):1314-9.
    doi: 10.2460/javma.241.10.1314pubmed: 23113523google scholar: lookup
  29. Graham-Thiers PM, Kronfeld DS. Amino acid supplementation improves muscle mass in aged and young horses.. J Anim Sci 2005 Dec;83(12):2783-8.
    doi: 10.2527/2005.83122783xpubmed: 16282616google scholar: lookup
  30. Maile CA, Hingst JR, Mahalingan KK, O'Reilly AO, Cleasby ME, Mickelson JR, McCue ME, Anderson SM, Hurley TD, Wojtaszewski JFP, Piercy RJ. A highly prevalent equine glycogen storage disease is explained by constitutive activation of a mutant glycogen synthase.. Biochim Biophys Acta Gen Subj 2017 Jan;1861(1 Pt A):3388-3398.
    pmc: PMC5148651pubmed: 27592162doi: 10.1016/j.bbagen.2016.08.021google scholar: lookup
  31. Tsujino S, Nonaka I, DiMauro S. Glycogen storage myopathies.. Neurol Clin 2000 Feb;18(1):125-50.
    pubmed: 10658171doi: 10.1016/s0733-8619(05)70181-xgoogle scholar: lookup
  32. Pedersen S, Windeyer C, Read E, French D, Cribb A, Macleod H. Prevalence of And Risk Factors for Gastric Ulceration In Showjumping Warmbloods.. Journal of Veterinary Internal Medicine 2015 July 1;29(4):1239.
  33. McClure SR, Carithers DS, Gross SJ, Murray MJ. Gastric ulcer development in horses in a simulated show or training environment.. J Am Vet Med Assoc 2005 Sep 1;227(5):775-7.
    pubmed: 16178400doi: 10.2460/javma.2005.227.775google scholar: lookup

Citations

This article has been cited 2 times.
  1. Williams ZJ, Velez-Irizarry D, Gardner K, Valberg SJ. Integrated proteomic and transcriptomic profiling identifies aberrant gene and protein expression in the sarcomere, mitochondrial complex I, and the extracellular matrix in Warmblood horses with myofibrillar myopathy. BMC Genomics 2021 Jun 11;22(1):438.
    doi: 10.1186/s12864-021-07758-0pubmed: 34112090google scholar: lookup
  2. Williams ZJ, Velez-Irizarry D, Petersen JL, Ochala J, Finno CJ, Valberg SJ. Candidate gene expression and coding sequence variants in Warmblood horses with myofibrillar myopathy. Equine Vet J 2021 Mar;53(2):306-315.
    doi: 10.1111/evj.13286pubmed: 32453872google scholar: lookup
Subscribe to our newsletter
Join 99,344 horse owners like you who receive our email updates on horse health and nutrition.